{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:47:58Z","timestamp":1793742478256,"version":"4.6.1"},"reference-count":124,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s10787-025-01778-y","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T14:42:34Z","timestamp":1747320154000},"page":"2885-2906","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["PDE4 inhibitors in psoriasis therapy: current insights and future directions"],"prefix":"10.1007","volume":"33","author":[{"given":"Amit","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niyati","family":"Pandoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keerti","family":"Dayal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Raj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirandeep","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navjot Kaur","family":"Sandhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vineet Kumar","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubham","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8470-6622","authenticated-orcid":false,"given":"Balak Das","family":"Kurmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,15]]},"reference":[{"key":"1778_CR1","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/J.BBRC.2003.11.108","volume":"313","author":"SC Ahn","year":"2004","unstructured":"Ahn SC, Kim GY, Kim JH et al (2004) Epigallocatechin-3-gallate, constituent of green tea, suppresses the LPS-induced phenotypic and functional maturation of murine dendritic cells through inhibition of mitogen-activated protein kinases and NF-\u03baB. Biochem Biophys Res Commun 313:148\u2013155. https:\/\/doi.org\/10.1016\/J.BBRC.2003.11.108","journal-title":"Biochem Biophys Res Commun"},{"key":"1778_CR2","doi-asserted-by":"publisher","first-page":"e0305934","DOI":"10.1371\/JOURNAL.PONE.0305934","volume":"19","author":"AR Alanzi","year":"2024","unstructured":"Alanzi AR, Alsalhi MS, Mothana RA et al (2024) Insilico discovery of novel phosphodiesterase 4 (PDE4) inhibitors for the treatment of psoriasis: insights from computer aided drug design approaches. PLoS ONE 19:e0305934. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0305934","journal-title":"PLoS ONE"},{"key":"1778_CR3","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/JAMA.2020.4006","volume":"323","author":"AW Armstrong","year":"2020","unstructured":"Armstrong AW, Read C (2020) Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA 323:1945\u20131960. https:\/\/doi.org\/10.1001\/JAMA.2020.4006","journal-title":"JAMA"},{"key":"1778_CR4","doi-asserted-by":"publisher","first-page":"696597","DOI":"10.3389\/FMED.2021.696597","volume":"8","author":"S Arora","year":"2021","unstructured":"Arora S, Das P, Arora G (2021) Systematic review and recommendations to combine newer therapies with conventional therapy in psoriatic disease. Front Med (Lausanne) 8:696597. https:\/\/doi.org\/10.3389\/FMED.2021.696597","journal-title":"Front Med (Lausanne)"},{"key":"1778_CR5","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1210\/ER.2013-1053","volume":"35","author":"MF Azevedo","year":"2014","unstructured":"Azevedo MF, Faucz FR, Bimpaki E et al (2014) Clinical and molecular genetics of the phosphodiesterases (PDEs). Endocr Rev 35:195\u2013233. https:\/\/doi.org\/10.1210\/ER.2013-1053","journal-title":"Endocr Rev"},{"issue":"4","key":"1778_CR6","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/S13555-020-00409-4","volume":"10","author":"DMW Balak","year":"2020","unstructured":"Balak DMW, Gerdes S, Parodi A, Salgado-Boquete L (2020) Long-term safety of oral systemic therapies for psoriasis: a comprehensive review of the literature. Dermatol Ther 10(4):589\u2013613. https:\/\/doi.org\/10.1007\/S13555-020-00409-4","journal-title":"Dermatol Ther"},{"key":"1778_CR7","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/J.ABD.2021.03.001","volume":"96","author":"NDM Barros","year":"2021","unstructured":"Barros NDM, Sbroglio LL, Buffara MDO et al (2021) Phototherapy. An Bras Dermatol 96:397\u2013407. https:\/\/doi.org\/10.1016\/J.ABD.2021.03.001","journal-title":"An Bras Dermatol"},{"issue":"6","key":"1778_CR8","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nrd2060","volume":"5","author":"JA Baur","year":"2006","unstructured":"Baur JA, Sinclair DA (2006) Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5(6):493\u2013506. https:\/\/doi.org\/10.1038\/nrd2060","journal-title":"Nat Rev Drug Discov"},{"key":"1778_CR9","doi-asserted-by":"publisher","first-page":"e15099","DOI":"10.1371\/JOURNAL.PONE.0015099","volume":"5","author":"S Bereswill","year":"2010","unstructured":"Bereswill S, Mu\u00f1oz M, Fischer A et al (2010) Anti-inflammatory effects of resveratrol, curcumin and simvastatin in acute small intestinal inflammation. PLoS ONE 5:e15099. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0015099","journal-title":"PLoS ONE"},{"key":"1778_CR10","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1080\/17425255.2016.1206886","volume":"12","author":"L Bianchi","year":"2016","unstructured":"Bianchi L, Del Duca E, Romanelli M et al (2016) Pharmacodynamic assessment of apremilast for the treatment of moderate-to-severe plaque psoriasis. Expert Opin Drug Metab Toxicol 12:1121\u20131128. https:\/\/doi.org\/10.1080\/17425255.2016.1206886","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"1778_CR11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/NYAS.13401","volume":"1403","author":"L Biasutto","year":"2017","unstructured":"Biasutto L, Mattarei A, Azzolini M et al (2017) Resveratrol derivatives as a pharmacological tool. Ann N Y Acad Sci 1403:27\u201337. https:\/\/doi.org\/10.1111\/NYAS.13401","journal-title":"Ann N Y Acad Sci"},{"key":"1778_CR12","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/JDV.14647","volume":"32","author":"R Bissonnette","year":"2018","unstructured":"Bissonnette R, Haydey R, Rosoph LA et al (2018) Apremilast for the treatment of moderate-to-severe palmoplantar psoriasis: results from a double-blind, placebo-controlled, randomized study. J Eur Acad Dermatol Venereol 32:403\u2013410. https:\/\/doi.org\/10.1111\/JDV.14647","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1778_CR13","doi-asserted-by":"publisher","first-page":"3031","DOI":"10.1007\/S13555-023-01054-3","volume":"13","author":"A Blauvelt","year":"2023","unstructured":"Blauvelt A, Langley RG, Gordon KB et al (2023) Next generation PDE4 inhibitors that selectively target PDE4B\/D subtypes: a narrative review. Dermatol Ther (Heidelb) 13:3031. https:\/\/doi.org\/10.1007\/S13555-023-01054-3","journal-title":"Dermatol Ther (Heidelb)"},{"key":"1778_CR14","doi-asserted-by":"publisher","first-page":"6507","DOI":"10.3390\/IJMS23126507","volume":"23","author":"F Borgia","year":"2022","unstructured":"Borgia F, Custurone P, Li Pomi FL et al (2022a) IL-31: state of the art for an inflammation-oriented interleukin. Int J Mol Sci 23:6507. https:\/\/doi.org\/10.3390\/IJMS23126507","journal-title":"Int J Mol Sci"},{"key":"1778_CR15","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.3390\/BIOM12121904","volume":"12","author":"F Borgia","year":"2022","unstructured":"Borgia F, Li Pomi F, Vaccaro M et al (2022b) Oxidative stress and phototherapy in atopic dermatitis: mechanisms, role, and future perspectives. Biomolecules 12:1904. https:\/\/doi.org\/10.3390\/BIOM12121904","journal-title":"Biomolecules"},{"key":"1778_CR16","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/J.INTIMP.2016.03.025","volume":"35","author":"M Bros","year":"2016","unstructured":"Bros M, Montermann E, Cholaszczy\u0144ska A, Reske-Kunz AB (2016) The phosphodiesterase 4 inhibitor roflumilast augments the Th17-promoting capability of dendritic cells by enhancing IL-23 production, and impairs their T cell stimulatory activity due to elevated IL-10. Int Immunopharmacol 35:174\u2013184. https:\/\/doi.org\/10.1016\/J.INTIMP.2016.03.025","journal-title":"Int Immunopharmacol"},{"key":"1778_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/9783429","volume":"2019","author":"S Bungau","year":"2019","unstructured":"Bungau S, Abdel-Daim MM, Tit DM, Ghanem E, Sato S, Maruyama-Inoue M, Yamane S, Kadonosono K (2019) Health benefits of polyphenols and carotenoids in age-related eye diseases. Oxid Med Cell Longevity 2019:1\u201322","journal-title":"Oxid Med Cell Longevity"},{"key":"1778_CR18","doi-asserted-by":"publisher","first-page":"1508489","DOI":"10.3389\/FIMMU.2024.1508489\/BIBTEX","volume":"15","author":"E Campione","year":"2024","unstructured":"Campione E, Cosio T, Pistoia ES et al (2024) Prevalence of fungal colonization among patients with psoriasis in difficult-to-treat areas: impact of apremilast on mycotic burden and clinical outcomes. Front Immunol 15:1508489. https:\/\/doi.org\/10.3389\/FIMMU.2024.1508489\/BIBTEX","journal-title":"Front Immunol"},{"key":"1778_CR19","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3390\/NU14040819","volume":"14","author":"G Caruso","year":"2022","unstructured":"Caruso G, Godos J, Privitera A et al (2022) Phenolic acids and prevention of cognitive decline: polyphenols with a neuroprotective role in cognitive disorders and Alzheimer\u2019s disease. Nutrients 14:819. https:\/\/doi.org\/10.3390\/NU14040819","journal-title":"Nutrients"},{"issue":"29","key":"1778_CR20","first-page":"5","volume":"2017","author":"J Choi","year":"2017","unstructured":"Choi J, Kim B, Youn SW (2017) Adherence to topical therapies for the treatment of psoriasis: surveys of physicians and patients. Ann Dermatol 2017(29):5\u2013559","journal-title":"Ann Dermatol"},{"key":"1778_CR21","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1111\/CED.14676","volume":"46","author":"JY Choi","year":"2021","unstructured":"Choi JY, Owusu-Ayim M, Dawe R et al (2021) Narrowband ultraviolet B phototherapy is associated with a reduction in topical corticosteroid and clinical improvement in atopic dermatitis: a historical inception cohort study. Clin Exp Dermatol 46:1067\u20131074. https:\/\/doi.org\/10.1111\/CED.14676","journal-title":"Clin Exp Dermatol"},{"key":"1778_CR22","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1182\/BLOOD.V128.22.2938.2938","volume":"128","author":"J Cooney","year":"2016","unstructured":"Cooney J, Wang L, Lin A-P et al (2016) Synergism between PDE4 and PI3K\u03b4 inhibitors in DLBCL: improved clinical activity with the potential for lower toxicity. Blood 128:2938\u20132938. https:\/\/doi.org\/10.1182\/BLOOD.V128.22.2938.2938","journal-title":"Blood"},{"key":"1778_CR23","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/PHARMACEUTICS16010023","volume":"16","author":"EL Crowley","year":"2023","unstructured":"Crowley EL, Gooderham MJ (2023) Phosphodiesterase-4 Inhibition in the Management of Psoriasis. Pharmaceutics 16:23. https:\/\/doi.org\/10.3390\/PHARMACEUTICS16010023","journal-title":"Pharmaceutics"},{"key":"1778_CR24","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/J.JDERMSCI.2014.08.010","volume":"76","author":"T Dainichi","year":"2014","unstructured":"Dainichi T, Hanakawa S, Kabashima K (2014) Classification of inflammatory skin diseases: a proposal based on the disorders of the three-layered defense systems, barrier, innate immunity and acquired immunity. J Dermatol Sci 76:81\u201389. https:\/\/doi.org\/10.1016\/J.JDERMSCI.2014.08.010","journal-title":"J Dermatol Sci"},{"key":"1778_CR25","doi-asserted-by":"publisher","first-page":"6","DOI":"10.5070\/D3216027825","volume":"21","author":"MJ Danesh","year":"2015","unstructured":"Danesh MJ, Beroukhim K, Nguyen C et al (2015) Apremilast and adalimumab: a novel combination therapy for recalcitrant psoriasis. Dermatol Online J 21:6. https:\/\/doi.org\/10.5070\/D3216027825","journal-title":"Dermatol Online J"},{"key":"1778_CR26","doi-asserted-by":"publisher","first-page":"239","DOI":"10.4103\/IJD.IJD_548_18","volume":"64","author":"A De","year":"2019","unstructured":"De A, Das S, Dhoot D, Sarda A (2019) Apremilast coadministered with secukinumab for safe and effective control of psoriasis with resultant reduction of maintenance dose of the biologic. Indian J Dermatol 64:239. https:\/\/doi.org\/10.4103\/IJD.IJD_548_18","journal-title":"Indian J Dermatol"},{"key":"1778_CR27","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.3390\/NU9121306","volume":"29","author":"AL de Brito Oliveira","year":"2017","unstructured":"de Brito Oliveira AL, Monteiro VVS, Navegantes-Lima KC et al (2017) Resveratrol role in autoimmune disease\u2014a mini-review. Nutrients 29:1306. https:\/\/doi.org\/10.3390\/NU9121306","journal-title":"Nutrients"},{"key":"1778_CR28","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/JOCD.13093","volume":"19","author":"DJ de Lima Cherubim","year":"2020","unstructured":"de Lima Cherubim DJ, Buzanello Martins CV, Oliveira Fari\u00f1a L, da Silva de Lucca RA (2020) Polyphenols as natural antioxidants in cosmetics applications. J Cosmet Dermatol 19:33\u201337. https:\/\/doi.org\/10.1111\/JOCD.13093","journal-title":"J Cosmet Dermatol"},{"key":"1778_CR29","doi-asserted-by":"publisher","first-page":"3579","DOI":"10.3390\/PLANTS12203579","volume":"12","author":"E Di Salvo","year":"2023","unstructured":"Di Salvo E, Gangemi S, Genovese C et al (2023) Polyphenols from Mediterranean plants: biological activities for skin photoprotection in atopic dermatitis, psoriasis, and chronic urticaria. Plants 12:3579. https:\/\/doi.org\/10.3390\/PLANTS12203579","journal-title":"Plants"},{"key":"1778_CR30","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/J.PHRS.2017.08.002","volume":"124","author":"M Dvorakova","year":"2017","unstructured":"Dvorakova M, Landa P (2017) Anti-inflammatory activity of natural stilbenoids: a review. Pharmacol Res 124:126\u2013145. https:\/\/doi.org\/10.1016\/J.PHRS.2017.08.002","journal-title":"Pharmacol Res"},{"key":"1778_CR31","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/J.JAAD.2017.06.010","volume":"77","author":"LF Eichenfield","year":"2017","unstructured":"Eichenfield LF, Call RS, Forsha DW et al (2017) Long-term safety of crisaborole ointment 2% in children and adults with mild to moderate atopic dermatitis. J Am Acad Dermatol 77:641-649.e5. https:\/\/doi.org\/10.1016\/J.JAAD.2017.06.010","journal-title":"J Am Acad Dermatol"},{"key":"1778_CR32","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1007\/S40262-018-0671-4\/FIGURES\/5","volume":"57","author":"A Facius","year":"2018","unstructured":"Facius A, Marostica E, Gardiner P et al (2018) Pharmacokinetic and pharmacodynamic modelling to characterize the tolerability of alternative up-titration regimens of roflumilast in patients with chronic obstructive pulmonary disease. Clin Pharmacokinet 57:1029\u20131038. https:\/\/doi.org\/10.1007\/S40262-018-0671-4\/FIGURES\/5","journal-title":"Clin Pharmacokinet"},{"key":"1778_CR33","doi-asserted-by":"publisher","first-page":"5301","DOI":"10.1021\/JF900344D","volume":"57","author":"BM Fahlman","year":"2009","unstructured":"Fahlman BM, Krol ES (2009) Inhibition of UVA and UVB radiation-induced lipid oxidation by quercetin. J Agric Food Chem 57:5301\u20135305. https:\/\/doi.org\/10.1021\/JF900344D","journal-title":"J Agric Food Chem"},{"key":"1778_CR34","first-page":"9","volume":"146","author":"E Farley","year":"2011","unstructured":"Farley E, Menter A (2011) Psoriasis: comorbidities and associations. G Ital Dermatol Venereol 146:9\u201315","journal-title":"G Ital Dermatol Venereol"},{"key":"1778_CR35","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3390\/PLANTS8120537","volume":"8","author":"J Fej\u00e9r","year":"2019","unstructured":"Fej\u00e9r J, Kron I, Pellizzeri V et al (2019) First report on evaluation of basic nutritional and antioxidant properties of Moringa oleifera Lam. from Caribbean Island of Saint Lucia. Plants 8:537. https:\/\/doi.org\/10.3390\/PLANTS8120537","journal-title":"Plants"},{"key":"1778_CR36","first-page":"36","volume":"9","author":"BIRC Ferreira","year":"2016","unstructured":"Ferreira BIRC, Da Costa Abreu JLP, Dos Reis JPG, Da Costa Figueiredo AM (2016) Psoriasis and associated psychiatric disorders: a systematic review on etiopathogenesis and clinical correlation. J Clin Aesthet Dermatol 9:36","journal-title":"J Clin Aesthet Dermatol"},{"key":"1778_CR37","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/JCDD5010008","volume":"5","author":"BA Fertig","year":"2018","unstructured":"Fertig BA, Baillie GS (2018) PDE4-mediated cAMP signalling. J Cardiovasc Dev Dis 5:8. https:\/\/doi.org\/10.3390\/JCDD5010008","journal-title":"J Cardiovasc Dev Dis"},{"key":"1778_CR38","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/J.JAAD.2023.11.068","volume":"90","author":"L Fiorillo","year":"2024","unstructured":"Fiorillo L, Becker E, de Lucas R et al (2024) Efficacy and safety of apremilast in pediatric patients with moderate-to-severe plaque psoriasis: 16-week results from SPROUT, a randomized controlled trial. J Am Acad Dermatol 90:1232\u20131239. https:\/\/doi.org\/10.1016\/J.JAAD.2023.11.068","journal-title":"J Am Acad Dermatol"},{"key":"1778_CR39","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/J.JAIP.2019.06.044","volume":"8","author":"AB Fishbein","year":"2020","unstructured":"Fishbein AB, Silverberg JI, Wilson EJ, Ong PY (2020) Update on atopic dermatitis: diagnosis, severity assessment, and treatment selection. J Allergy Clin Immunol Pract 8:91\u2013101. https:\/\/doi.org\/10.1016\/J.JAIP.2019.06.044","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1778_CR40","doi-asserted-by":"publisher","first-page":"19","DOI":"10.18388\/abp.2018_2749","volume":"20","author":"S Galiniak","year":"2019","unstructured":"Galiniak S, Aebisher D, Bartusik-Aebisher D (2019) Health benefits of resveratrol administration. Acta Biochim Polon 20:19. https:\/\/doi.org\/10.18388\/abp.2018_2749","journal-title":"Acta Biochim Polon"},{"key":"1778_CR41","doi-asserted-by":"publisher","first-page":"395","DOI":"10.2147\/CCID.S266036","volume":"15","author":"JC Gao","year":"2022","unstructured":"Gao JC, Wu AG, Contento MN et al (2022) Apremilast in the treatment of plaque psoriasis: differential use in psoriasis. Clin Cosmet Investig Dermatol 15:395\u2013402. https:\/\/doi.org\/10.2147\/CCID.S266036","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"1778_CR42","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/J.JACI.2012.06.048","volume":"131","author":"JK Gittler","year":"2013","unstructured":"Gittler JK, Krueger JG, Guttman-Yassky E (2013) Atopic dermatitis results in intrinsic barrier and immune abnormalities: implications for contact dermatitis. J Allergy Clin Immunol 131:300\u2013313. https:\/\/doi.org\/10.1016\/J.JACI.2012.06.048","journal-title":"J Allergy Clin Immunol"},{"key":"1778_CR43","doi-asserted-by":"publisher","first-page":"114962","DOI":"10.1016\/J.EJMECH.2022.114962","volume":"246","author":"L Grau","year":"2023","unstructured":"Grau L, Soucek R, Pujol MD (2023) Resveratrol derivatives: synthesis and their biological activities. Eur J Med Chem 246:114962. https:\/\/doi.org\/10.1016\/J.EJMECH.2022.114962","journal-title":"Eur J Med Chem"},{"key":"1778_CR44","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3390\/DISEASES4030028","volume":"4","author":"K Griffiths","year":"2016","unstructured":"Griffiths K, Aggarwal BB, Singh RB et al (2016) Food antioxidants and their anti-inflammatory properties: a potential role in cardiovascular diseases and cancer prevention. Diseases 4:28. https:\/\/doi.org\/10.3390\/DISEASES4030028","journal-title":"Diseases"},{"key":"1778_CR45","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/S40257-022-00703-1\/METRICS","volume":"23","author":"M Gyldenl\u00f8ve","year":"2022","unstructured":"Gyldenl\u00f8ve M, Alinaghi F, Zachariae C et al (2022) Combination therapy with apremilast and biologics for psoriasis: a systematic review. Am J Clin Dermatol 23:605\u2013613. https:\/\/doi.org\/10.1007\/S40257-022-00703-1\/METRICS","journal-title":"Am J Clin Dermatol"},{"key":"1778_CR46","doi-asserted-by":"publisher","first-page":"e13106","DOI":"10.1111\/SJI.13106","volume":"95","author":"L Han","year":"2022","unstructured":"Han L, Fu Q, Deng C et al (2022) Immunomodulatory potential of flavonoids for the treatment of autoimmune diseases and tumour. Scand J Immunol 95:e13106. https:\/\/doi.org\/10.1111\/SJI.13106","journal-title":"Scand J Immunol"},{"key":"1778_CR47","doi-asserted-by":"publisher","DOI":"10.3899\/JRHEUM.2024-0791","author":"R Hansildaar","year":"2025","unstructured":"Hansildaar R, van Geel EH, \u00c7oban F et al (2025) Cardio-metabolic effects of apremilast in patients with psoriatic arthritis: a prospective cohort study. J Rheumatol. https:\/\/doi.org\/10.3899\/JRHEUM.2024-0791","journal-title":"J Rheumatol"},{"key":"1778_CR48","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1007\/S10753-023-01805-6","volume":"46","author":"Y He","year":"2023","unstructured":"He Y, Jia H, Yang Q et al (2023) Specific activation of CB2R ameliorates psoriasis-like skin lesions by inhibiting inflammation and oxidative stress. Inflammation 46:1255\u20131271. https:\/\/doi.org\/10.1007\/S10753-023-01805-6","journal-title":"Inflammation"},{"key":"1778_CR49","doi-asserted-by":"publisher","first-page":"R7","DOI":"10.1016\/j.jaci.2009.07.012","volume":"124","author":"MD Howell","year":"2009","unstructured":"Howell MD, Kim BE, Gao P et al (2009) Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol 124:R7\u2013R12. https:\/\/doi.org\/10.1016\/j.jaci.2009.07.012","journal-title":"J Allergy Clin Immunol"},{"key":"1778_CR50","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1248\/BPB.31.955","volume":"31","author":"CF Hung","year":"2008","unstructured":"Hung CF, Lin YK, Huang ZR, Fang JY (2008) Delivery of resveratrol, a red wine polyphenol, from solutions and hydrogels via the skin. Biol Pharm Bull 31:955\u2013962. https:\/\/doi.org\/10.1248\/BPB.31.955","journal-title":"Biol Pharm Bull"},{"key":"1778_CR51","doi-asserted-by":"publisher","first-page":"4075","DOI":"10.1039\/C6FO01067A","volume":"7","author":"A Ishihata","year":"2016","unstructured":"Ishihata A, Maruki-Uchida H, Gotoh N et al (2016) Vascular- and hepato-protective effects of passion fruit seed extract containing piceatannol in chronic high-fat diet-fed rats. Food Funct 7:4075\u20134081. https:\/\/doi.org\/10.1039\/C6FO01067A","journal-title":"Food Funct"},{"key":"1778_CR52","doi-asserted-by":"publisher","first-page":"837","DOI":"10.36849\/JDD.5845","volume":"20","author":"MG Ivanic","year":"2021","unstructured":"Ivanic MG, Thatiparthi A, Walia S et al (2021) Review of apremilast combination therapies in the treatment of moderate to severe psoriasis. J Drugs Dermatol 20:837\u2013843. https:\/\/doi.org\/10.36849\/JDD.5845","journal-title":"J Drugs Dermatol"},{"key":"1778_CR53","doi-asserted-by":"publisher","first-page":"391","DOI":"10.2174\/156802607779941242","volume":"7","author":"H Ke","year":"2007","unstructured":"Ke H, Wang H (2007) Crystal structures of phosphodiesterases and implications on substrate specificity and inhibitor selectivity. Curr Top Med Chem 7:391\u2013403. https:\/\/doi.org\/10.2174\/156802607779941242","journal-title":"Curr Top Med Chem"},{"key":"1778_CR54","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/J.JEP.2011.04.072","volume":"137","author":"J Kim","year":"2011","unstructured":"Kim J, Lee CW, Kim EK et al (2011) Inhibition effect of Gynura procumbens extract on UV-B-induced matrix-metalloproteinase expression in human dermal fibroblasts. J Ethnopharmacol 137:427\u2013433. https:\/\/doi.org\/10.1016\/J.JEP.2011.04.072","journal-title":"J Ethnopharmacol"},{"key":"1778_CR55","doi-asserted-by":"publisher","first-page":"5302","DOI":"10.3390\/IJMS25105302","volume":"25","author":"HJ Kim","year":"2024","unstructured":"Kim HJ, Kim YH, Wertz PW et al (2024) Exploring acne treatments: from pathophysiological mechanisms to emerging therapies. Int J Mol Sci 25:5302. https:\/\/doi.org\/10.3390\/IJMS25105302","journal-title":"Int J Mol Sci"},{"key":"1778_CR56","doi-asserted-by":"publisher","first-page":"465","DOI":"10.4196\/KJPP.2017.21.5.465","volume":"21","author":"F Kong","year":"2017","unstructured":"Kong F, Zhang R, Zhao X et al (2017) Resveratrol raises in vitro anticancer effects of paclitaxel in NSCLC cell line A549 through COX-2 expression. Korean J Physiol Pharmacol 21:465\u2013474. https:\/\/doi.org\/10.4196\/KJPP.2017.21.5.465","journal-title":"Korean J Physiol Pharmacol"},{"key":"1778_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1532\/JCOPDF.2021.0272","volume":"9","author":"JA Krishnan","year":"2021","unstructured":"Krishnan JA, Albert RK, Rennard SI (2021) Waiting for actionable evidence: roflumilast or azithromycin? Chronic obstructive pulmonary diseases. J COPD Found 9:1. https:\/\/doi.org\/10.1532\/JCOPDF.2021.0272","journal-title":"J COPD Found"},{"key":"1778_CR58","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.3390\/NU12061717","volume":"12","author":"YS Ku","year":"2020","unstructured":"Ku YS, Ng MS, Cheng SS et al (2020) Understanding the composition, biosynthesis, accumulation and transport of flavonoids in crops for the promotion of crops as healthy sources of flavonoids for human consumption. Nutrients 12:1717. https:\/\/doi.org\/10.3390\/NU12061717","journal-title":"Nutrients"},{"key":"1778_CR59","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/S40257-021-00649-W\/METRICS","volume":"23","author":"AM L\u00e9","year":"2022","unstructured":"L\u00e9 AM, Torres T (2022) New topical therapies for psoriasis. Am J Clin Dermatol 23:13\u201324. https:\/\/doi.org\/10.1007\/S40257-021-00649-W\/METRICS","journal-title":"Am J Clin Dermatol"},{"key":"1778_CR60","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/J.JAAD.2013.12.018","volume":"70","author":"MG Lebwohl","year":"2014","unstructured":"Lebwohl MG, Bachelez H, Barker J et al (2014) Patient perspectives in the management of psoriasis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey. J Am Acad Dermatol 70:871-881.e30. https:\/\/doi.org\/10.1016\/J.JAAD.2013.12.018","journal-title":"J Am Acad Dermatol"},{"key":"1778_CR61","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1056\/NEJMOA2000073\/SUPPL_FILE\/NEJMOA2000073_DATA-SHARING.PDF","volume":"383","author":"MG Lebwohl","year":"2020","unstructured":"Lebwohl MG, Papp KA, Stein Gold L et al (2020) Trial of roflumilast cream for chronic plaque psoriasis. N Engl J Med 383:229\u2013239. https:\/\/doi.org\/10.1056\/NEJMOA2000073\/SUPPL_FILE\/NEJMOA2000073_DATA-SHARING.PDF","journal-title":"N Engl J Med"},{"key":"1778_CR62","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1001\/JAMA.2022.15632","volume":"328","author":"MG Lebwohl","year":"2022","unstructured":"Lebwohl MG, Kircik LH, Moore AY et al (2022) Effect of roflumilast cream vs vehicle cream on chronic plaque psoriasis: the DERMIS-1 and DERMIS-2 randomized clinical trials. JAMA 328:1073\u20131084. https:\/\/doi.org\/10.1001\/JAMA.2022.15632","journal-title":"JAMA"},{"key":"1778_CR63","doi-asserted-by":"publisher","first-page":"790712","DOI":"10.3389\/FPHAR.2022.790712\/FULL","volume":"13","author":"L Li","year":"2022","unstructured":"Li L, Liu X, Ge W et al (2022) CB2R deficiency exacerbates imiquimod-induced psoriasiform dermatitis and itch through the neuro-immune pathway. Front Pharmacol 13:790712. https:\/\/doi.org\/10.3389\/FPHAR.2022.790712\/FULL","journal-title":"Front Pharmacol"},{"key":"1778_CR64","doi-asserted-by":"publisher","first-page":"15","DOI":"10.38212\/2224-6614.1151","volume":"29","author":"MH Lin","year":"2021","unstructured":"Lin MH, Hung CF, Sung HC et al (2021) The bioactivities of resveratrol and its naturally occurring derivatives on skin. J Food Drug Anal 29:15\u201338. https:\/\/doi.org\/10.38212\/2224-6614.1151","journal-title":"J Food Drug Anal"},{"key":"1778_CR65","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/J.PHARMTHERA.2005.07.003","volume":"109","author":"C Lugnier","year":"2006","unstructured":"Lugnier C (2006) Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents. Pharmacol Ther 109:366\u2013398. https:\/\/doi.org\/10.1016\/J.PHARMTHERA.2005.07.003","journal-title":"Pharmacol Ther"},{"key":"1778_CR66","doi-asserted-by":"publisher","first-page":"106070","DOI":"10.1016\/J.INTIMP.2019.106070","volume":"79","author":"J Lv","year":"2020","unstructured":"Lv J, Zhou D, Wang Y et al (2020) Effects of luteolin on treatment of psoriasis by repressing HSP90. Int Immunopharmacol 79:106070. https:\/\/doi.org\/10.1016\/J.INTIMP.2019.106070","journal-title":"Int Immunopharmacol"},{"key":"1778_CR67","doi-asserted-by":"publisher","first-page":"962","DOI":"10.5114\/ADA.2019.88465","volume":"37","author":"K Malinowska","year":"2019","unstructured":"Malinowska K, Wo\u017aniacka A, Bogaczewicz J (2019) The impact of medium dose UVA1 phototherapy on pruritus, DLQI and SCORAD index in patients with atopic dermatitis. Adv Dermatol Allergol\/post\u0119py Dermatologii i Alergologii 37:962\u2013967. https:\/\/doi.org\/10.5114\/ADA.2019.88465","journal-title":"Adv Dermatol Allergol\/post\u0119py Dermatologii i Alergologii"},{"key":"1778_CR68","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.3390\/ANTIOX12111954","volume":"12","author":"M Marko","year":"2023","unstructured":"Marko M, Pawliczak R (2023) Resveratrol and its derivatives in inflammatory skin disorders\u2014atopic dermatitis and psoriasis: a review. Antioxidants 12:1954. https:\/\/doi.org\/10.3390\/ANTIOX12111954","journal-title":"Antioxidants"},{"key":"1778_CR69","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/S0140-6736(14)62410-7","volume":"385","author":"FJ Martinez","year":"2015","unstructured":"Martinez FJ, Calverley PMA, Goehring UM et al (2015) Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trial. Lancet 385:857\u2013866. https:\/\/doi.org\/10.1016\/S0140-6736(14)62410-7","journal-title":"Lancet"},{"key":"1778_CR70","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/S40257-023-00783-7","volume":"24","author":"PJ Mease","year":"2023","unstructured":"Mease PJ, Hatemi G, Paris M et al (2023) Apremilast long-term safety up to 5 years from 15 pooled randomized, placebo-controlled studies of psoriasis, psoriatic arthritis, and Beh\u00e7et\u2019s syndrome. Am J Clin Dermatol 24:809\u2013820. https:\/\/doi.org\/10.1007\/S40257-023-00783-7","journal-title":"Am J Clin Dermatol"},{"key":"1778_CR71","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1136\/ANNRHEUMDIS-2024-EULAR.2405","volume":"83","author":"PJ Mease","year":"2024","unstructured":"Mease PJ, Maksymowych WP, Boesen M et al (2024) POS0968 apremilast reduces inflammation as measured by MRI, clinical outcomes, and patient-reported outcomes in patients with psoriatic arthritis: results from the phase 4 mosaic study. Ann Rheum Dis 83:704\u2013705. https:\/\/doi.org\/10.1136\/ANNRHEUMDIS-2024-EULAR.2405","journal-title":"Ann Rheum Dis"},{"key":"1778_CR72","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/J.JAAD.2023.10.020","volume":"90","author":"JF Merola","year":"2024","unstructured":"Merola JF, Parish LC, Guenther L et al (2024) Efficacy and safety of apremilast in patients with moderate-to-severe genital psoriasis: results from DISCREET, a phase 3 randomized, double-blind, placebo-controlled trial. J Am Acad Dermatol 90:485\u2013493. https:\/\/doi.org\/10.1016\/J.JAAD.2023.10.020","journal-title":"J Am Acad Dermatol"},{"key":"1778_CR73","doi-asserted-by":"publisher","first-page":"234","DOI":"10.2174\/1573397115666181130094455","volume":"15","author":"S Metyas","year":"2018","unstructured":"Metyas S, Tomassian C, Messiah R et al (2018) Combination therapy of apremilast and biologic agent as a safe option of psoriatic arthritis and psoriasis. Curr Rheumatol Rev 15:234\u2013237. https:\/\/doi.org\/10.2174\/1573397115666181130094455","journal-title":"Curr Rheumatol Rev"},{"key":"1778_CR74","doi-asserted-by":"publisher","first-page":"234","DOI":"10.2174\/1573397115666181130094455","volume":"15","author":"S Metyas","year":"2019","unstructured":"Metyas S, Tomassian C, Messiah R et al (2019) Combination therapy of apremilast and biologic agent as a safe option of psoriatic arthritis and psoriasis. Curr Rheumatol Rev 15:234\u2013237. https:\/\/doi.org\/10.2174\/1573397115666181130094455","journal-title":"Curr Rheumatol Rev"},{"key":"1778_CR75","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2147\/PTT.S303634","volume":"11","author":"M Milakovic","year":"2021","unstructured":"Milakovic M, Gooderham MJ (2021) Phosphodiesterase-4 inhibition in psoriasis. Psoriasis Targets Ther 11:21. https:\/\/doi.org\/10.2147\/PTT.S303634","journal-title":"Psoriasis Targets Ther"},{"key":"1778_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12950-015-0097-9\/FIGURES\/7","volume":"12","author":"SY Min","year":"2015","unstructured":"Min SY, Yan M, Kim SB et al (2015) Green tea epigallocatechin-3-gallate suppresses autoimmune arthritis through indoleamine-2,3-dioxygenase expressing dendritic cells and the nuclear factor, erythroid 2-like 2 antioxidant pathway. J Inflamm (United Kingdom) 12:1\u201315. https:\/\/doi.org\/10.1186\/S12950-015-0097-9\/FIGURES\/7","journal-title":"J Inflamm (United Kingdom)"},{"key":"1778_CR77","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/JDV.18689","volume":"37","author":"U Mrowietz","year":"2023","unstructured":"Mrowietz U, Barker J, Conrad C et al (2023) Efficacy and safety of apremilast in patients with limited skin involvement, plaque psoriasis in special areas and impaired quality of life: results from the EMBRACE randomized trial. J Eur Acad Dermatol Venereol 37:348\u2013355. https:\/\/doi.org\/10.1111\/JDV.18689","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1778_CR78","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/S000110050500\/METRICS","volume":"48","author":"A M\u00fcschen","year":"1999","unstructured":"M\u00fcschen A, Mirmohammadsadegh A, Jarzebska-Deussen B et al (1999) Differential IL-10 receptor gene expression in acute versus chronic atonic eczema. Modulation by immunosuppressive drugs and cytokines in normal cultured keratinocytes. Inflamm Res 48:539\u2013543. https:\/\/doi.org\/10.1007\/S000110050500\/METRICS","journal-title":"Inflamm Res"},{"key":"1778_CR79","doi-asserted-by":"publisher","DOI":"10.7759\/CUREUS.19182","author":"E Myers","year":"2021","unstructured":"Myers E, Kheradmand S, Miller R et al (2021) An update on narrowband ultraviolet B therapy for the treatment of skin diseases. Cureus. https:\/\/doi.org\/10.7759\/CUREUS.19182","journal-title":"Cureus"},{"key":"1778_CR80","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.2174\/092986712799945085","volume":"19","author":"AR Neves","year":"2012","unstructured":"Neves AR, Lucio M, Lima JLC, Reis S (2012) Resveratrol in medicinal chemistry: a critical review of its pharmacokinetics, drug-delivery, and membrane interactions. Curr Med Chem 19:1663\u20131681. https:\/\/doi.org\/10.2174\/092986712799945085","journal-title":"Curr Med Chem"},{"key":"1778_CR81","doi-asserted-by":"publisher","first-page":"60","DOI":"10.5152\/EURJRHEUM.2018.17188","volume":"6","author":"MK Nisar","year":"2018","unstructured":"Nisar MK (2018) Combining secukinumab and apremilast to successfully treat refractory psoriatic skin and joint disease: a novel approach. Eur J Rheumatol 6:60. https:\/\/doi.org\/10.5152\/EURJRHEUM.2018.17188","journal-title":"Eur J Rheumatol"},{"key":"1778_CR82","doi-asserted-by":"publisher","first-page":"560682","DOI":"10.1155\/2012\/560682","volume":"2012","author":"P Oyetakinwhite","year":"2012","unstructured":"Oyetakinwhite P, Tribout H, Baron E (2012) Protective mechanisms of green tea polyphenols in skin. Oxid Med Cell Longev 2012:560682. https:\/\/doi.org\/10.1155\/2012\/560682","journal-title":"Oxid Med Cell Longev"},{"key":"1778_CR83","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/S0140-6736(12)60642-4","volume":"380","author":"K Papp","year":"2012","unstructured":"Papp K, Cather JC, Rosoph L et al (2012) Efficacy of apremilast in the treatment of moderate to severe psoriasis: a randomised controlled trial. Lancet 380:738\u2013746. https:\/\/doi.org\/10.1016\/S0140-6736(12)60642-4","journal-title":"Lancet"},{"key":"1778_CR84","doi-asserted-by":"publisher","DOI":"10.1111\/J.1468-3083.2012.04716.X","author":"KA Papp","year":"2013","unstructured":"Papp KA, Kaufmann R, Tha\u00e7i D et al (2013) Efficacy and safety of apremilast in subjects with moderate to severe plaque psoriasis: results from a phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison study. J Eur Acad Dermatol Venereol. https:\/\/doi.org\/10.1111\/J.1468-3083.2012.04716.X","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1778_CR85","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/J.JAAD.2015.03.049","volume":"73","author":"K Papp","year":"2015","unstructured":"Papp K, Reich K, Leonardi CL et al (2015) Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1). J Am Acad Dermatol 73:37\u201349. https:\/\/doi.org\/10.1016\/J.JAAD.2015.03.049","journal-title":"J Am Acad Dermatol"},{"key":"1778_CR86","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1111\/BJD.14164","volume":"173","author":"C Paul","year":"2015","unstructured":"Paul C, Cather J, Gooderham M et al (2015) Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate-to-severe plaque psoriasis over 52 weeks: a phase III, randomized controlled trial (ESTEEM 2). Br J Dermatol 173:1387\u20131399. https:\/\/doi.org\/10.1111\/BJD.14164","journal-title":"Br J Dermatol"},{"key":"1778_CR87","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/J.MRREV.2011.11.001","volume":"750","author":"H Piotrowska","year":"2012","unstructured":"Piotrowska H, Kucinska M, Murias M (2012) Biological activity of piceatannol: leaving the shadow of resveratrol. Mutation Res\/rev Mutation Res 750:60\u201382. https:\/\/doi.org\/10.1016\/J.MRREV.2011.11.001","journal-title":"Mutation Res\/rev Mutation Res"},{"key":"1778_CR88","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1177\/10600280221137750","volume":"57","author":"JN Pixley","year":"2022","unstructured":"Pixley JN, Schaetzle T, Feldman SR (2022) A review of topical roflumilast for the treatment of plaque psoriasis. Ann Pharmacother 57:966\u2013969. https:\/\/doi.org\/10.1177\/10600280221137750","journal-title":"Ann Pharmacother"},{"key":"1778_CR89","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1684\/EJD.2015.2663\/METRICS","volume":"26","author":"A Rafael","year":"2016","unstructured":"Rafael A, Torres T (2016) Topical therapy for psoriasis: a promising future. Focus on JAK and phosphodiesterase-4 inhibitors. Eur J Dermatol 26:3\u20138. https:\/\/doi.org\/10.1684\/EJD.2015.2663\/METRICS","journal-title":"Eur J Dermatol"},{"key":"1778_CR90","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/IBD.21843","volume":"18","author":"K Rahal","year":"2012","unstructured":"Rahal K, Schmiedlin-Ren P, Adler J et al (2012) Resveratrol has antiinflammatory and antifibrotic effects in the peptidoglycan-polysaccharide rat model of Crohn\u2019s disease. Inflamm Bowel Dis 18:613\u2013623. https:\/\/doi.org\/10.1002\/IBD.21843","journal-title":"Inflamm Bowel Dis"},{"key":"1778_CR91","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/J.AUTREV.2014.01.008","volume":"13","author":"SK Raychaudhuri","year":"2014","unstructured":"Raychaudhuri SK, Maverakis E, Raychaudhuri SP (2014) Diagnosis and classification of psoriasis. Autoimmun Rev 13:490\u2013495. https:\/\/doi.org\/10.1016\/J.AUTREV.2014.01.008","journal-title":"Autoimmun Rev"},{"key":"1778_CR92","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1111\/JDV.17520","volume":"35","author":"K Reich","year":"2021","unstructured":"Reich K, Mrowietz U, Menter A et al (2021) Effect of baseline disease severity on achievement of treatment target with apremilast: results from a pooled analysis. J Eur Acad Dermatol Venereol 35:2409\u20132414. https:\/\/doi.org\/10.1111\/JDV.17520","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1778_CR93","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.3390\/IJMS20061475","volume":"20","author":"A Rendon","year":"2019","unstructured":"Rendon A, Sch\u00e4kel K (2019) Psoriasis pathogenesis and treatment. Int J Mol Sci 20:1475. https:\/\/doi.org\/10.3390\/IJMS20061475","journal-title":"Int J Mol Sci"},{"key":"1778_CR94","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1177\/1203475420960429","volume":"25","author":"Z Ridha","year":"2020","unstructured":"Ridha Z, Ouchene L, Netchiporouk E, Gooderham MJ (2020) Topical PDE-4 inhibitors are emerging for psoriasis treatment. J Cutan Med Surg 25:109\u2013110. https:\/\/doi.org\/10.1177\/1203475420960429","journal-title":"J Cutan Med Surg"},{"key":"1778_CR95","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/J.1440-0960.2004.00078.X","volume":"45","author":"PAJ Russo","year":"2004","unstructured":"Russo PAJ, Ilchef R, Cooper A (2004) Psychiatric morbidity in psoriasis: a review. Australas J Dermatol 45:155\u2013161. https:\/\/doi.org\/10.1111\/J.1440-0960.2004.00078.X","journal-title":"Australas J Dermatol"},{"key":"1778_CR96","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/J.JCONREL.2016.09.029","volume":"241","author":"AS Rzhevskiy","year":"2016","unstructured":"Rzhevskiy AS, Guy RH, Anissimov YG (2016) Modelling drug flux through microporated skin. J Control Release 241:194\u2013199. https:\/\/doi.org\/10.1016\/J.JCONREL.2016.09.029","journal-title":"J Control Release"},{"key":"1778_CR97","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3390\/BIOMEDICINES6030091","volume":"6","author":"B Salehi","year":"2018","unstructured":"Salehi B, Mishra AP, Nigam M et al (2018) Resveratrol: a double-edged sword in health benefits. Biomedicines 6:91. https:\/\/doi.org\/10.3390\/BIOMEDICINES6030091","journal-title":"Biomedicines"},{"key":"1778_CR98","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1089\/JMF.2019.0098","volume":"22","author":"ED Sezer","year":"2019","unstructured":"Sezer ED, Oktay LM, Karadada\u015f E et al (2019) Assessing anticancer potential of blueberry flavonoids, quercetin, kaempferol, and gentisic acid, through oxidative stress and apoptosis parameters on HCT-116 Cells. J Med Food 22:1118\u20131126. https:\/\/doi.org\/10.1089\/JMF.2019.0098","journal-title":"J Med Food"},{"key":"1778_CR99","doi-asserted-by":"publisher","first-page":"24","DOI":"10.2174\/2589977513666210707114520","volume":"14","author":"A Sharma","year":"2021","unstructured":"Sharma A, Upadhyay DK, Das GG et al (2021) IL-23\/Th17 axis: a potential therapeutic target of psoriasis. Curr Drug Res Rev 14:24\u201336. https:\/\/doi.org\/10.2174\/2589977513666210707114520","journal-title":"Curr Drug Res Rev"},{"key":"1778_CR100","doi-asserted-by":"publisher","first-page":"49","DOI":"10.5344\/AJEV.1992.43.1.49","volume":"43","author":"EH Siemann","year":"1992","unstructured":"Siemann EH, Creasy LL (1992) Concentration of the phytoalexin resveratrol in wine. Am J Enol Vitic 43:49\u201352. https:\/\/doi.org\/10.5344\/AJEV.1992.43.1.49","journal-title":"Am J Enol Vitic"},{"key":"1778_CR101","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/BF02977608\/METRICS","volume":"30","author":"GS Sim","year":"2007","unstructured":"Sim GS, Lee BC, Ho SC et al (2007) Structure activity relationship of antioxidative property of flavonoids and inhibitory effect on matrix metalloproteinase activity in UVA-irradiated human dermal fibroblast. Arch Pharm Res 30:290\u2013298. https:\/\/doi.org\/10.1007\/BF02977608\/METRICS","journal-title":"Arch Pharm Res"},{"key":"1778_CR102","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1001\/JAMADERMATOL.2024.3121","volume":"160","author":"EL Simpson","year":"2024","unstructured":"Simpson EL, Eichenfield LF, Alonso-Llamazares J et al (2024) Roflumilast cream, 0.15%, for atopic dermatitis in adults and children: INTEGUMENT-1 and INTEGUMENT-2 randomized clinical trials. JAMA Dermatol 160:1161. https:\/\/doi.org\/10.1001\/JAMADERMATOL.2024.3121","journal-title":"JAMA Dermatol"},{"key":"1778_CR103","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1093\/JAOAC\/102.5.1397","volume":"102","author":"RK Singla","year":"2019","unstructured":"Singla RK, Dubey AK, Garg A et al (2019) Natural polyphenols: chemical classification, definition of classes, subcategories, and structures. J AOAC Int 102:1397\u20131400. https:\/\/doi.org\/10.1093\/JAOAC\/102.5.1397","journal-title":"J AOAC Int"},{"key":"1778_CR104","doi-asserted-by":"publisher","first-page":"4238","DOI":"10.1021\/acs.jmedchem.1c02058","volume":"65","author":"Z Song","year":"2022","unstructured":"Song Z, Huang YY, Hou KQ et al (2022) Discovery and structural optimization of toddacoumalone derivatives as novel PDE4 inhibitors for the topical treatment of psoriasis. J Med Chem 65:4238\u20134254. https:\/\/doi.org\/10.1021\/acs.jmedchem.1c02058","journal-title":"J Med Chem"},{"key":"1778_CR105","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/J.JAAD.2021.07.040","volume":"86","author":"L Stein Gold","year":"2022","unstructured":"Stein Gold L, Papp K, Pariser D et al (2022) Efficacy and safety of apremilast in patients with mild-to-moderate plaque psoriasis: results of a phase 3, multicenter, randomized, double-blind, placebo-controlled trial. J Am Acad Dermatol 86:77\u201385. https:\/\/doi.org\/10.1016\/J.JAAD.2021.07.040","journal-title":"J Am Acad Dermatol"},{"key":"1778_CR106","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/S40257-022-00741-9\/TABLES\/4","volume":"24","author":"AW Thurston","year":"2023","unstructured":"Thurston AW, Osborne DW, Snyder S et al (2023) Pharmacokinetics of Roflumilast cream in chronic plaque psoriasis: data from phase I to phase III studies. Am J Clin Dermatol 24:315\u2013324. https:\/\/doi.org\/10.1007\/S40257-022-00741-9\/TABLES\/4","journal-title":"Am J Clin Dermatol"},{"key":"1778_CR107","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/PDE.12780","volume":"33","author":"WL Tom","year":"2016","unstructured":"Tom WL, Van Syoc M, Chanda S, Zane LT (2016) Pharmacokinetic profile, safety, and tolerability of crisaborole topical ointment, 2% in adolescents with atopic dermatitis: an open-label phase 2a study. Pediatr Dermatol 33:150\u2013159. https:\/\/doi.org\/10.1111\/PDE.12780","journal-title":"Pediatr Dermatol"},{"key":"1778_CR108","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/J.COLSURFB.2016.09.045","volume":"148","author":"MJ Tsai","year":"2016","unstructured":"Tsai MJ, Lu IJ, Fu YS et al (2016) Nanocarriers enhance the transdermal bioavailability of resveratrol: in-vitro and in-vivo study. Colloids Surf B Biointerfaces 148:650\u2013656. https:\/\/doi.org\/10.1016\/J.COLSURFB.2016.09.045","journal-title":"Colloids Surf B Biointerfaces"},{"key":"1778_CR109","doi-asserted-by":"publisher","first-page":"107784","DOI":"10.1016\/J.PHARMTHERA.2020.107784","volume":"222","author":"PA Vieyra-Garcia","year":"2021","unstructured":"Vieyra-Garcia PA, Wolf P (2021) A deep dive into UV-based phototherapy: mechanisms of action and emerging molecular targets in inflammation and cancer. Pharmacol Ther 222:107784. https:\/\/doi.org\/10.1016\/J.PHARMTHERA.2020.107784","journal-title":"Pharmacol Ther"},{"key":"1778_CR110","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/J.1749-6632.2010.05842.X","volume":"1215","author":"T Walle","year":"2011","unstructured":"Walle T (2011) Bioavailability of resveratrol. Ann N Y Acad Sci 1215:9\u201315. https:\/\/doi.org\/10.1111\/J.1749-6632.2010.05842.X","journal-title":"Ann N Y Acad Sci"},{"key":"1778_CR111","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1042\/BJ20070970","volume":"408","author":"H Wang","year":"2007","unstructured":"Wang H, Peng MS, Chen Y et al (2007) Structures of the four subfamilies of phosphodiesterase-4 provide insight into the selectivity of their inhibitors. Biochemical J 408:193\u2013201. https:\/\/doi.org\/10.1042\/BJ20070970","journal-title":"Biochemical J"},{"key":"1778_CR112","doi-asserted-by":"publisher","first-page":"3649","DOI":"10.1021\/JF104718G","volume":"59","author":"KT Wang","year":"2011","unstructured":"Wang KT, Chen LG, Tseng SH et al (2011) Anti-inflammatory effects of resveratrol and oligostilbenes from Vitis thunbergii var. taiwaniana against lipopolysaccharide-induced arthritis. J Agric Food Chem 59:3649\u20133656. https:\/\/doi.org\/10.1021\/JF104718G","journal-title":"J Agric Food Chem"},{"key":"1778_CR113","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1080\/09546634.2019.1577546","volume":"30","author":"Y Wang","year":"2019","unstructured":"Wang Y, Coyne K, Sofen H et al (2019) Qualitative analysis and reproducibility assessment of the Scalp Itch Numeric Rating Scale among patients with moderate to severe plaque psoriasis of the scalp. J Dermatolog Treat 30:775\u2013783. https:\/\/doi.org\/10.1080\/09546634.2019.1577546","journal-title":"J Dermatolog Treat"},{"key":"1778_CR114","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/J.JAAD.2023.11.005","volume":"90","author":"RB Warren","year":"2024","unstructured":"Warren RB, French LE, Blauvelt A et al (2024) Orismilast in moderate-to-severe psoriasis: efficacy and safety from a 16-week, randomized, double-blinded, placebo-controlled, dose-finding, and phase 2b trial (IASOS). J Am Acad Dermatol 90:494\u2013503. https:\/\/doi.org\/10.1016\/J.JAAD.2023.11.005","journal-title":"J Am Acad Dermatol"},{"key":"1778_CR115","doi-asserted-by":"publisher","first-page":"6413","DOI":"10.4049\/JIMMUNOL.1001829","volume":"185","author":"AY Wen","year":"2010","unstructured":"Wen AY, Sakamoto KM, Miller LS (2010) The role of the transcription factor CREB in immune function. J Immunol 185:6413\u20136419. https:\/\/doi.org\/10.4049\/JIMMUNOL.1001829","journal-title":"J Immunol"},{"key":"1778_CR116","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S13555-013-0023-0","volume":"3","author":"M Wittmann","year":"2013","unstructured":"Wittmann M, Helliwell PS (2013) Phosphodiesterase 4 inhibition in the treatment of psoriasis, psoriatic arthritis and other chronic inflammatory diseases. Dermatol Ther (Heidelb) 3:1. https:\/\/doi.org\/10.1007\/S13555-013-0023-0","journal-title":"Dermatol Ther (Heidelb)"},{"key":"1778_CR117","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jdermsci.2014.03.004","volume":"75","author":"Z Wu","year":"2014","unstructured":"Wu Z, Uchi H, Morino-Koga S et al (2014) Resveratrol inhibition of human keratinocyte proliferation via SIRT1\/ARNT\/ERK dependent downregulation of aquaporin 3. J Dermatol Sci 75:16\u201323. https:\/\/doi.org\/10.1016\/j.jdermsci.2014.03.004","journal-title":"J Dermatol Sci"},{"key":"1778_CR118","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/PHPP.12741","volume":"38","author":"H Xiao","year":"2022","unstructured":"Xiao H, Gu X, Huang Y et al (2022) Phototherapy for atopic dermatitis: systematic review and network meta-analysis of randomized controlled trials. Photodermatol Photoimmunol Photomed 38:233\u2013240. https:\/\/doi.org\/10.1111\/PHPP.12741","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"1778_CR119","doi-asserted-by":"publisher","first-page":"5383","DOI":"10.53730\/IJHS.V6NS6.10667","volume":"6","author":"SK Yadav","year":"2022","unstructured":"Yadav SK, Singh VD, Mazumder A (2022) Newly discovered biologic agent used for psoriasis treatment. Int J Health Sci (Qassim) 6:5383\u20135392. https:\/\/doi.org\/10.53730\/IJHS.V6NS6.10667","journal-title":"Int J Health Sci (Qassim)"},{"key":"1778_CR120","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/1346-8138.15913","volume":"48","author":"K Yamanaka","year":"2021","unstructured":"Yamanaka K, Yamamoto O, Honda T (2021) Pathophysiology of psoriasis: a review. J Dermatol 48:722\u2013731. https:\/\/doi.org\/10.1111\/1346-8138.15913","journal-title":"J Dermatol"},{"key":"1778_CR121","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/S40257-020-00578-0","volume":"22","author":"K Yang","year":"2020","unstructured":"Yang K, Oak ASW, Elewski BE (2020) Use of IL-23 inhibitors for the treatment of plaque psoriasis and psoriatic arthritis: a comprehensive review. Am J Clin Dermatol 22:173. https:\/\/doi.org\/10.1007\/S40257-020-00578-0","journal-title":"Am J Clin Dermatol"},{"key":"1778_CR122","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1038\/mt.2016.175","volume":"24","author":"S Yu","year":"2016","unstructured":"Yu S, Pearson AD, Lim RKV et al (2016) Targeted delivery of an anti-inflammatory PDE4 inhibitor to immune cells via an antibody-drug conjugate. Mol Ther 24:2078\u20132089. https:\/\/doi.org\/10.1038\/mt.2016.175","journal-title":"Mol Ther"},{"key":"1778_CR123","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/1346-8138.13806","volume":"44","author":"J Zeng","year":"2017","unstructured":"Zeng J, Luo S, Huang Y, Lu Q (2017) Critical role of environmental factors in the pathogenesis of psoriasis. J Dermatol 44:863\u2013872. https:\/\/doi.org\/10.1111\/1346-8138.13806","journal-title":"J Dermatol"},{"key":"1778_CR124","doi-asserted-by":"publisher","first-page":"903160","DOI":"10.3389\/FPHAR.2022.903160\/BIBTEX","volume":"13","author":"S Zhang","year":"2022","unstructured":"Zhang S, Wang J, Liu L et al (2022) Efficacy and safety of curcumin in psoriasis: preclinical and clinical evidence and possible mechanisms. Front Pharmacol 13:903160. https:\/\/doi.org\/10.3389\/FPHAR.2022.903160\/BIBTEX","journal-title":"Front Pharmacol"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01778-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-025-01778-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01778-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T15:05:07Z","timestamp":1751382307000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-025-01778-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,15]]},"references-count":124,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["1778"],"URL":"https:\/\/doi.org\/10.1007\/s10787-025-01778-y","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,15]]},"assertion":[{"value":"9 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there is no conflict of interest, financial or otherwise.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statements"}}]}}